UAMS Myeloma Center
The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
Total Therapy Approach
At the core of the successful outcomes at the Myeloma Center is a treatment approach that combines chemotherapy with autologous stem cell transplantation followed by a maintenance strategy.
Learn moreWinter 2024/2025 Myeloma Magazine
The goal of Myeloma is to provide timely updates about progress in clinical treatment and research advances, as well as stories and information of general interest.
Read MagazineMyeloma Center: Behind the Scenes
Majid Asgari, Ph.D. Majid Asgari, Ph.D., is a postdoctoral fellow in the UAMS College of Medicine Department of Internal Medicine. He earned his doctorate in medical biotechnology from the Pasteur Institute of Iran in 2021 and joined the UAMS Myeloma Center in 2024 in the lab of research director Fenghuang “Frank” Zhan, M.D., Ph.D. His…
News & Announcements
Publications
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages Blood Cancer Journal November 2024 Primary authors: Yan Cheng, Ph.D.; Fumou Sun, Ph.D. Tumor immune microenvironmental alterations occur early in multiple myeloma development. In this study, we aim to systematically characterize the tumor immune microenvironment (TME) and the tumor-immune interactions from precursor stages,…
Read more
Infusion B: A Welcoming Setting for Blood Cancer Patients
Five years after its opening, Infusion B at the Winthrop P. Rockefeller Cancer Institute continues to play a vital role in the transformational care that blood cancer patients receive at the University of Arkansas for Medical Sciences (UAMS). The state-of-the-art center, which opened in late 2020 on the institute’s sixth floor, sees patients with such…
Read more
Myeloma Patient Thankful for Chance to Participate in Clinical Trial
Gary Robertson thinks his multiple myeloma diagnosis came at good time, if such a thing is possible. “I’d never any had health issues to speak of,” said the 73-year-old Robertson, whose multiple myeloma diagnosis coincided with a groundbreaking clinical trial at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute. His…
Read more
Cancer Institute’s Clinical Research Team Guides Myeloma Clinical Trials
The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) is the state’s leader in cancer clinical trials. Clinical trials are conducted for purposes such as studying new drugs or drug combinations, reviewing a new method of performing surgeries or using existing treatments, or researching ways to prevent diseases. The…
Read moreWant to read more stories like these?